Curewel Biotech Private Limited - Company Profile

It is a healthcare private limited company based in Delhi, Delhi, India, established in 2006.
2006 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Curewel Biotech Private Limited

Curewel Biotech Private Limited, a struck off private limited company, was established on 29 December 2006 in Delhi, Delhi, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85120DL2006PTC157196. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rakesh Kumar (Director), Anil Singla (Director). Past directors included Lalit Mohan, Sandeep Majumdar. Its latest AGM occurred on 29 September 2008, with the balance sheet filed on 31 March 2008. It is based at 1709/2, Mittal Medical Market Bhagirath Place, Delhi, Delhi, 110006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85120DL2006PTC157196

  • Registration Number

    157196

  • Incorporation Date

    29 December 2006

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 19 Year, 3 Months
  • Last Filing with ROC 31 Mar 2008
Company report

Curewel Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Curewel Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Curewel Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Rakesh Kumar Director 21 Mar 2010 Current
Anil Singla Director 31 Aug 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Apr 2010 Past
Pramod Abcsdd Director 02 Apr 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Curewel Biotech.

Enhance accessibility to Curewel Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Curewel Biotech revenue growth over time
Curewel Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Curewel Biotech?

Unlock access to Curewel Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Curewel Biotech?

Unlock and access historical data on people associated with Curewel Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Curewel Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curewel Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Curewel Biotech
Recent Activity within the Organization
  • Director Appointment

    The activity Rakesh Kumar was appointed as a Director was appointed as a Director on 21 Mar 2010 & has been associated with this company since 16 years 8 days . was completed.

  • Annual General Meeting

    Progress on Curewel Biotech Private Limited last Annual general meeting of members was held on 29 Sep 2008 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Curewel Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2008 with Roc Delhi. was documented.

  • Director Appointment

    Anil Singla was appointed as a Director was appointed as a Director on 31 Aug 2007 & has been associated with this company since 18 years 6 months . was recorded as a recent event.

  • Company Incorporation

    Curewel Biotech Private Limited was registered on 29 Dec 2006 with Roc Delhi & aged 19 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Curewel Biotech Private Limited?

The CIN of Curewel Biotech Private Limited is U85120DL2006PTC157196.

Where is Curewel Biotech Private Limited headquartered?

Curewel Biotech Private Limited is headquartered at 1709/2, Mittal Medical Market Bhagirath Place, Delhi, Delhi, 110006.

When was Curewel Biotech Private Limited incorporated?

Curewel Biotech Private Limited was incorporated on 29 December 2006.

Who are the current directors of Curewel Biotech Private Limited?

The current directors of Curewel Biotech Private Limited are

What is the primary industry of Curewel Biotech Private Limited?

The primary industry of Curewel Biotech Private Limited is Healthcare.

Is Curewel Biotech Private Limited a listed company?

Curewel Biotech Private Limited is unlisted.

What is the capital structure of Curewel Biotech Private Limited?

The authorized capital of Curewel Biotech Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available